Latest Breaking News On - Srinivasr sadda - Page 1 : comparemela.com

Precursor lesions may help identify risk for atrophy in AMD

Precursor lesions may help identify risk for atrophy in AMD
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Christine-klimanskis
Byalex-young
Srinivasr-sadda

Samsung Bioepis Presents Post-hoc Analysis of Phase 3

Switching study conducted to evaluate whether switching from reference aflibercept to SB15 maintains comparable clinical efficacy and safetyPost-hoc.

Amsterdam
Noord-holland
Netherlands
United-states
American
Sergei-astakhov
Ranibizumab-biosimilar
Yeeun-kim
Aflibercept-biosimilar
Attila-vajas
Edward-wylegala
Samsung-bioepis

Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Clinical Trial for SB15, a Proposed Biosimilar to Eyleaⁱ (Aflibercept), at EURETINA 2023

Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Clinical Trial for SB15, a Proposed Biosimilar to Eyleaⁱ (Aflibercept), at EURETINA 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amsterdam
Noord-holland
Netherlands
United-states
American
Attila-vajas
Hyerin-jang
Adrienne-csutak
Jan-studnicka
Jan-ernest
Neilm-bressler
Ranibizumab-biosimilar

Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Clinical Trial for SB15, a Proposed Biosimilar to Eylea? (Aflibercept), at EURETINA 2023

Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Clinical Trial for SB15, a Proposed Biosimilar to Eylea? (Aflibercept), at EURETINA 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Netherlands
United-states
Amsterdam
Noord-holland
American
Sergei-astakhov
Jan-ernest
Seungkee-kim
Edward-wylegala
Michal-orski
Taehyung-kim
Cheolmin-yun

Uncontrolled Wet AMD: Drug Switch Can Mute Disease Activity

Phase 3 data from the 2023 ARVO meeting showed treatment with the monoclonal antibody improved visual acuity in some patients.

Australia
Paris
France-general
France
Sydney
New-south-wales
Australian
Ramin-tadayoni
Mark-gillies
Brolucizumab-beovu
Iveric-bio
Srinivasr-sadda